开发新药来逆转神经肌肉阻塞:我们需要它们吗?
Jennifer M Hunter1, Manfred Blobner2
1University of Liverpool, Institute of Ageing and Chronic Disease, Liverpool, UK.
罗库和苏加马德克斯是常见的麻醉药物. 新的逆转药物正在开发中,尽管由于对改善神经肌肉阻断逆转的需求有限,其临床需求受到质疑.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 罗库和sugammadex在麻醉期间广泛用于神经肌肉阻塞逆转.
- 尽管它们已经确立了有效性和安全性,但对新型逆转剂的研究仍在进行中.
研究的目的:
- 审查当前的神经肌肉阻塞逆转剂的情况.
- 讨论开发新的药物,如阿达姆加马德克斯,卡拉巴迪安2和Pillar[6]MaxQ.
- 评估这些新药的临床必要性.
主要方法:
- 关于神经肌肉阻塞逆转的最新进展的文献综述.
- 分析新出现的逆转剂及其作用机制.
- 讨论临床需求和开发新药的理由.
主要成果:
- 苏加马德克斯是当前用于逆转罗库的标准.
- 新的药物正在开发中,包括修改后的环氧和无关的化合物.
- 这些新型药物旨在隔离罗库和潜在的其他药物,如芬太尼.
结论:
- 新的神经肌肉逆转剂的开发仍在继续.
- 除了苏加玛克斯之外,对其他药物的临床需求是有限的.
- 麻醉药理学正在进行的研究旨在提高药物的安全性和疗效.
更多相关视频
10:57Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
04:44Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury
Published on: November 1, 2024
相关概念视频
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Neuromuscular Junction And Blockade
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
